Bullfrog AI Holdings, Inc. is a US-listed company in the biotechnology industry. Its financial year ends in December.
Stock price today
Loading chart…
Third-party market data · may be delayed
Fair value per share
Under review: every model's value for Bullfrog AI Holdings, Inc. is far from the share price, which usually points to a data problem (a merger, a share-count change, a one-off) rather than a bargain or a bubble.
Price vs value
Under review: limited reported history: available models are shown without a Buy/Hold/Sell rating. We'll show the comparison once resolved.
Bullfrog AI Holdings, Inc. valuation: adjust assumptions and compare models →
Who’s trading
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
- Insiders2 buying, 0 selling2 purchases and 0 sales by directors and officers, last 12 monthsInsider trades
- Funds16 adding, 8 cuttingOf 2 active managers that changed their stake, 1 added; quarter to June 30, 2026Fund buyers and sellers
The Fundamentalytics view
Current signal Share count rising (dilution): Diluted shares outstanding rose 45.7% year over year.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Highlights
How we pick theseStrengths
Nothing in Bullfrog AI Holdings, Inc.'s latest figures clears our strength thresholds.
Things to watch
- Share dilution. Diluted shares rose 45.7% in a year.
- Volatile shares. Over the past year the shares showed annualised volatility of 168% and a beta of 2.7 against the S&P 500.
- Short interest rising. Shares sold short rose 894% in a month to 6.3% of tradable shares.
Latest results: FY2026 Q2
- Earnings per share
- -$0.07 against an average estimate of -$0.11: beat by 36.4%
- Revenue
- $0m, up 547.6% on a year earlier
Price chart
- 1 day+1.6%
- 1 week+3.1%
- 1 month-19.7%
- This year-43.8%
- 1 year-61.3%
- S&P 500 this year+11.2%
Loading chart…
Third-party market data · may be delayed
At a glance
Profitability
- EPS (TTM, diluted)
- $-0.45
Growth
- Share count change
- +45.7%
Cash
- Free cash flow (TTM)
- -$5.5M
News & updates
Company announcements, filed results and changes that matter to shareholders.
No recent updates are available for BFRG from the sources we follow. See filings →
The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.
Valuation models
We value Bullfrog AI Holdings, Inc. as an operating company, with every model that fits that kind of business. Cost of equity 10.1%: the 10-year Treasury yield (4.9%) plus a beta of 1.15 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. | — | Does not apply: This model is withheld pending its input or assumption review. |
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | — | Does not apply: This model is withheld pending its input or assumption review. |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | — | Does not apply: This model is withheld pending its input or assumption review. |
| Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. | — | Does not apply: This model is withheld pending its input or assumption review. |
| Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. | ~$0.0 ~$0.0–$0.1 | Left out: out of range vs price (0.04x) |
| Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. | — | Combined value withheld. Review the individual models and their assumptions. |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Bullfrog AI Holdings, Inc. with Biotechnology in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
Valuation multiples over time Market data may be delayed
| At fiscal year end | 2023 | 2025 |
|---|---|---|
| Share price | $3.26 | $0.88 |
| Market value | $20m | $9m |
| + Net debt (− = net cash) | −$3m | −$2m |
| Enterprise value | $17m | $7m |
| Multiples | ||
| Price / sales | n/m | 78.2x |
| Price / earnings | — | — |
| Price / free cash flow | — | — |
| EV / EBITDA | — | — |
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.
Forecasts and guidance
Analysts' consensus
| Fiscal year | EPS | Growth | Revenue | Growth |
|---|---|---|---|---|
| Current | −$0.37 | — | $780000 | — |
| Next | −$0.17 | +54% | $5m | +573% |
How the EPS forecast has moved
In the last 30 days, 1 analyst raised Bullfrog AI Holdings, Inc.'s forecast and 0 cut it.
Average of analysts' published estimates (third-party data).
View chart data
| Period | Current fiscal year | Next fiscal year |
|---|---|---|
| 30 days ago | −$0.44 | −$0.21 |
| 7 days ago | −$0.44 | −$0.21 |
| Now | −$0.37 | −$0.17 |
Earnings against estimates
| Quarter to | Estimate | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | −$0.11 | −$0.07 | +36.4% |
Adjusted EPS as companies report it, against the average analyst estimate.
Positioning
- Short interest
- 6.3% of tradable shares
- Days to cover
- 0.07 at average volume
- Short interest, 1 month
- +894% to October 15, 2026
- Held by institutions
- 6% of shares
- Held by insiders
- 13.5% of shares
- Employees
- 9 full time
Share-price performance
Market data may be delayedReturn and risk by year
| Calendar year | 2024 | 2025 | 2026 to date |
|---|---|---|---|
| Return | |||
| BFRG | −39% | −56% | −44% |
| Industry peers (median) | −28% | −5% | −26% |
| S&P 500 | +25% | +18% | +11% |
| Months that ended higher | |||
| BFRG | 33% | 25% | 36% |
| S&P 500 | 75% | 75% | 46% |
| Largest fall from a high during the year | |||
| BFRG | −80% | −79% | −75% |
| S&P 500 | −8% | −19% | −9% |
Worst fall since February 13, 2023: 95% from April 20, 2023 to September 16, 2026. Getting back needed a 1937% gain, and the shares have not yet recovered.
Price behaviour
- 52-week range
- $0.43 – $1.68
- From 52-week high
- −70.5%
- vs 50-day average
- −10.4%
- vs 200-day average
- −23.9%
- Volatility (1 year)
- 168%
- Beta vs S&P 500
- 2.73
Fundamentals
Financial statements
| Fiscal year | 2022 Dec 2022 | 2023 Dec 2023 | 2025 Dec 2025 |
|---|---|---|---|
| Income | |||
| Revenue | 10 | 65 | 117 |
| Gross profit | 9 | 60 | 22 |
| EBITDA | −2,455 | −5,366 | −6,593 |
| Operating income | −2,456 | −5,368 | −6,595 |
| Net income | −2,802 | −5,356 | −6,498 |
| Diluted EPS | −$0.70 | −$0.89 | −$0.63 |
| Growth (year on year) | |||
| Revenue | — | +550.0% | +79.5% |
| Margins | |||
| Gross margin | 92.0% | 92.0% | 18.8% |
| EBITDA margin | <−999% | <−999% | <−999% |
| Operating margin | <−999% | <−999% | <−999% |
| Net margin | <−999% | <−999% | <−999% |
| Free-cash-flow margin | <−999% | <−999% | <−999% |
| Cash flow | |||
| Cash from operations | −911 | −6,001 | −5,522 |
| Capital spending | 9 | 0 | 0 |
| Free cash flow | −920 | −6,001 | −5,522 |
| Stock-based pay | 340 | 632 | 1,011 |
| Free cash flow after stock pay | −1,260 | −6,633 | −6,533 |
| Balance sheet | |||
| Cash | 58 | 2,625 | 2,184 |
| Total debt | 1,324 | 0 | 0 |
| Net debt (negative = net cash) | 1,266 | −2,625 | −2,184 |
| Diluted shares | 4m | 6m | 10m |
| Quarter | 2023 Q3 Sept 2023 | 2023 Q4 Dec 2023 | 2025 Q2 Jun 2025 | 2025 Q3 Sept 2025 | 2025 Q4 Dec 2025 | 2026 Q2 Jun 2026 |
|---|---|---|---|---|---|---|
| Income | ||||||
| Revenue | 65 | 0 | 33 | 83 | 0 | 215 |
| Gross profit | 60 | 0 | 7 | 15 | 0 | 107 |
| EBITDA | −1,304 | −1,335 | −1,469 | −1,569 | −1,498 | −1,419 |
| Operating income | −1,304 | −1,336 | −1,470 | −1,570 | −1,499 | −1,419 |
| Net income | −1,253 | −1,297 | −1,449 | −1,552 | −1,480 | −1,372 |
| Diluted EPS | −$0.21 | −$0.17 | −$0.15 | −$0.15 | −$0.12 | −$0.07 |
| Growth (year on year) | ||||||
| Revenue | — | — | — | — | — | +547.6% |
| Margins | ||||||
| Gross margin | 92.0% | — | 19.6% | 18.4% | — | 49.6% |
| EBITDA margin | <−999% | — | <−999% | <−999% | — | −658.6% |
| Operating margin | <−999% | — | <−999% | <−999% | — | −658.8% |
| Net margin | <−999% | — | <−999% | <−999% | — | −636.8% |
| Free-cash-flow margin | <−999% | — | <−999% | <−999% | — | −702.6% |
| Cash flow | ||||||
| Cash from operations | −1,394 | −1,018 | −1,432 | −1,107 | −1,185 | −1,513 |
| Capital spending | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | −1,394 | −1,018 | −1,432 | −1,107 | −1,185 | −1,513 |
| Stock-based pay | 116 | 120 | 178 | 145 | 154 | 1 |
| Free cash flow after stock pay | −1,510 | −1,138 | −1,610 | −1,253 | −1,339 | −1,514 |
Financial health
- Short-term assets cover short-term liabilities $7m of assets due within a year against $706,590 of liabilities due within a year.
- Short-term assets cover long-term liabilities $7m short-term assets against $0 of longer-dated liabilities.
- More cash than debt Cash or debt not separately reported. Not assessable.
- Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
- Operating profit covers interest at least five times over Operating income of −$6m against $5,520 of interest.
Dividends, buybacks and capital spending
- Diluted share count
- +45.7%
- year over year
Who owns it
Funds buying and selling- Reported value
- $947,046
- Institutions reporting
- 21
- Shares held vs prior quarter
- ▲ 121.3%
- Positions opened / closed
- 9 / 7
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| Citadel Advisors LLC | $256,698 | 362K | 27.1% | New |
| J. Safra Sarasin Holding AG | $191,050 | 114K | 20.2% | 0.0% |
| Vanguard Fiduciary Trust Co | $75,604 | 106K | 8.0% | ▲ 316.4% |
| Geode Capital Management, LLC | $74,498 | 105K | 7.9% | ▲ 31.4% |
| Vanguard Capital Management LLC | $65,033 | 92K | 6.9% | ▲ 37.6% |
| Vontobel Holding Ltd. | $49,700 | 70K | 5.2% | ▲ 84.2% |
| Jane Street Group, LLC | $46,846 | 66K | 4.9% | New |
| Act Advisors, Llc. | $40,009 | 56K | 4.2% | New |
| Fortem Financial Group, LLC | $35,500 | 50K | 3.7% | 0.0% |
| Raymond James Financial Inc | $31,532 | 44K | 3.3% | ▲ 196.1% |
| Northern Trust Corp | $16,710 | 24K | 1.8% | New |
| Two Sigma Securities, LLC | $15,384 | 22K | 1.6% | New |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Bullfrog AI Holdings, Inc.'s complete shareholder register. Values are as reported by the filers .
Insider trading activity
Full insider history and chart| Insider | Date | Trade | Shares | Price | Value |
|---|---|---|---|---|---|
| Singh Vininder Chief Executive Officer | September 22, 2026 | Buy | 75,000 | $0.60 | $45,000 |
| Blacher Joshua Chief Financial Officer | September 22, 2026 | Buy | 50,000 | $0.53 | $26,500 |
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
Earnings dates and SEC filings
Results announcements
Recent SEC filings
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- S-1 S-1
- 10-Q Quarterly report
- DEF 14A Proxy statement
- 8-K Current report
- 8-K Current report
Data status
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| Financial statements | SEC 10-K and 10-Q filings | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
Bullfrog AI Holdings, Inc. in brief
- What does Bullfrog AI Holdings, Inc. do?
- Bullfrog AI Holdings, Inc. is a US-listed company in the biotechnology industry. Its financial year ends in December.
- What is Bullfrog AI Holdings, Inc.'s stock ticker?
- Bullfrog AI Holdings, Inc. trades under the ticker BFRG on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
- Who are Bullfrog AI Holdings, Inc.'s largest institutional shareholders?
- By value reported in 13F filings for June 30, 2026, the largest reported holders are Citadel Advisors LLC, J. Safra Sarasin Holding AG and Vanguard Fiduciary Trust Co. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
- What is Bullfrog AI Holdings, Inc.'s market cap?
- On December 31, 2025, Bullfrog AI Holdings, Inc.'s market capitalisation was about $9.1M and net debt of -$2.2M. Market figures come from third-party market data and may be delayed.
- Are insiders buying or selling Bullfrog AI Holdings, Inc. stock?
- Over the last 12 months, Bullfrog AI Holdings, Inc.'s directors and officers reported 2 open-market purchases and 0 sales on Form 4. The insider trading page charts every trade.
Follow research on Bullfrog AI Holdings, Inc.
New research on the companies we cover arrives in the weekly email. Free, one email a week.